356 
Elite Controllers Are Enriched with HIV-specific Cells Expressing CD160 but Lacking PD-1
Yoav Peretz*1, Y Shi1, Z He1, B Bessette1, L Trautmann1, B Yassine-Diab1, C Tremblay1, N Bernard2, R-P Sékaly1, and E Haddad1
1Univ of Montreal, Canada and 2McGill Univ Hlth Ctr, Montreal, Canada
Background: CD160 is a
glycosylphosphatidylinositol (GPI) -anchored protein member of the
Ig-superfamily and expressed on cytotoxic T lymphocytes (CTL) and natural
killer (NK) cells. Engagement of CD160 on activated CD4 cells provides negative
signals to CD4 lymphocytes and inhibits proliferation. The interplay between co-stimulators
(CD28, LIGHT) and attenuators (BTLA, PD-1) ultimately determines the downstream
functions of responding lymphocytes. Therefore our study aims to characterize
the expression levels of CD160 on HIV and cytomegalovirus (CMV) tetramer-specific
cells during different stages of HIV disease and relate its expression to
markers of T cell exhaustion such as PD1
Methods: We analyzed the
relative expression of PD1 and CD160 on HIV- and CMV-specific cells from 45
HIV-infected individuals and 8 seronegative controls. We subdivided the
population into 5 groups: acute infection (n = 12; infected for <6 months),
chronic infection (n = 9; infected for >6 months), successfully treated (n =
12; undetectable viremia under HAART), and elite controllers (EC; n = 12;
undetectable viremia without treatment). Multiparametric flow cytometry was
used to analyze the memory phenotype (CM, TM, EM, naďve, and Temra cells) and
expression levels of CD160 and PD1 on tetramer-positive cells and on total CD8 and
CD4 T cells.
Results: Our results show
that the frequency of CD8 T cells expressing CD160 is higher in HIV infection
(33.7%) than in seronegative controls (24.3%). Interestingly, we found 3
phenotypically distinct populations of HIV-specific CD8 lymphocytes. EC
expressed significantly higher frequencies of PD1–CD160+
T cells (21.0%) than acute (14.9%), chronic (14.5%), and successfully treated
(12.7%) patients (p <0.05). However, CD8+PD1+CD160–
lymphocytes were found at higher frequencies in acutely infected individuals. Similarly,
the frequency of PD1–CD160+-expressing HIV-specific
tetramer cells from EC (25.4%) was significantly higher than from acute (7.1%),
chronic (10.2%), and successfully treated (12.3%) individuals (p <0.05,
t test). We found an inverse correlation between the expression of CD160
and PD1 on HIV-specific tetramers (r = –0.26, p = 0.02) and the
frequency of PD1+CD160–-expressing T cells positively
correlated with viral load, whereas PD1–CD160+ CD8 T
cells inversely correlated with viral load (p <0.05, Spearman rank).
Conclusions: Taken
together, our results show that CD160 is preferentially expressed on
HIV-specific cells isolated from individuals who spontaneously control viremia
and, unlike PD1, seems to be a marker of effective T cell responses
|